SI2231627T1 - Nov postopek za sintezo moguisteina - Google Patents

Nov postopek za sintezo moguisteina

Info

Publication number
SI2231627T1
SI2231627T1 SI200830359T SI200830359T SI2231627T1 SI 2231627 T1 SI2231627 T1 SI 2231627T1 SI 200830359 T SI200830359 T SI 200830359T SI 200830359 T SI200830359 T SI 200830359T SI 2231627 T1 SI2231627 T1 SI 2231627T1
Authority
SI
Slovenia
Prior art keywords
moguisteine
synthesis
methoxyphenoxy
methyl
new process
Prior art date
Application number
SI200830359T
Other languages
English (en)
Inventor
Enrico Vigano'
Massimiliano Arrighi
Renato Molteni
Simona Lanfranconi
Ernesto Landonio
Original Assignee
A M S A Anonima Materie Sint E Affini S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A M S A Anonima Materie Sint E Affini S P A filed Critical A M S A Anonima Materie Sint E Affini S P A
Publication of SI2231627T1 publication Critical patent/SI2231627T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SI200830359T 2007-12-03 2008-12-02 Nov postopek za sintezo moguisteina SI2231627T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07425770A EP2070915A1 (en) 2007-12-03 2007-12-03 New process for the synthesis of moguisteine
EP08857548A EP2231627B1 (en) 2007-12-03 2008-12-02 New process for the synthesis of moguisteine
PCT/EP2008/066591 WO2009071528A2 (en) 2007-12-03 2008-12-02 New process for the synthesis of moguisteine

Publications (1)

Publication Number Publication Date
SI2231627T1 true SI2231627T1 (sl) 2011-10-28

Family

ID=39450286

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830359T SI2231627T1 (sl) 2007-12-03 2008-12-02 Nov postopek za sintezo moguisteina

Country Status (12)

Country Link
EP (2) EP2070915A1 (sl)
KR (1) KR20110086503A (sl)
CN (1) CN101883761B (sl)
AT (1) ATE511505T1 (sl)
CY (1) CY1112328T1 (sl)
ES (1) ES2367466T3 (sl)
PL (1) PL2231627T3 (sl)
PT (1) PT2231627E (sl)
RS (1) RS51931B (sl)
RU (1) RU2492165C2 (sl)
SI (1) SI2231627T1 (sl)
WO (1) WO2009071528A2 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653527A (zh) * 2011-12-22 2012-09-05 东莞达信生物技术有限公司 一种莫吉司坦合成工艺
CN105399701A (zh) * 2013-01-06 2016-03-16 天津市汉康医药生物技术有限公司 噻唑烷衍生物、其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
IT1216119B (it) * 1988-03-17 1990-02-22 Boehringer Biochemia Srl Beta_carbonil_carbossiamidi di 1,3_tiazolidine.
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Also Published As

Publication number Publication date
EP2231627A2 (en) 2010-09-29
CN101883761B (zh) 2013-03-27
EP2070915A1 (en) 2009-06-17
EP2231627B1 (en) 2011-06-01
KR20110086503A (ko) 2011-07-28
RU2010127348A (ru) 2012-01-10
WO2009071528A3 (en) 2009-08-13
PT2231627E (pt) 2011-09-13
ATE511505T1 (de) 2011-06-15
RS51931B (en) 2012-02-29
CN101883761A (zh) 2010-11-10
ES2367466T3 (es) 2011-11-03
WO2009071528A2 (en) 2009-06-11
PL2231627T3 (pl) 2011-11-30
CY1112328T1 (el) 2015-12-09
RU2492165C2 (ru) 2013-09-10

Similar Documents

Publication Publication Date Title
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
IL209209A0 (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
FR2938536B1 (fr) Procede de fabrication d'un methacrylate de methyle derive de la biomasse
NZ610104A (en) Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
ATE550312T1 (de) Verfahren zur herstellung von 3,3,3- trifluorpropyn
WO2010088455A3 (en) Cromolyn derivatives and related methods of imaging and treatment
SG170729A1 (en) Processes and intermediates for preparing steric compounds
ATE502001T1 (de) Herstellung von essigsäure
FR2940801B1 (fr) Procede de fabrication d'un methacrylate de methyle derive de la biomasse
IL190551A0 (en) Novel process for the preparation of acid chlorides
WO2008096372A3 (en) Process for preparing highly pure ezetimibe using novel intermediates
HK1126756A1 (en) Process for preparation of hiv protease inhibitors
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
UA102220C2 (ru) Способ синтеза агомелатина
WO2007117591A3 (en) Total synthesis of salinosporamide a and analogs thereof
WO2009066735A1 (ja) ２－アザアダマンタン類の製造方法
WO2008126943A3 (en) Method for manufacturing neuraminic acid derivatives
PL2183201T3 (pl) Sposób rozdziału zopiklonu i związki pośrednie
SI2231627T1 (sl) Nov postopek za sintezo moguisteina
MX2011013057A (es) Metodo para producir derivado de benzotioamida 4-sustituida.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
WO2015022702A3 (en) Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof